Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03018548 · ClinicalTrials.gov registry record · NA
Improvised Explosive Device (IED) Level Blasting of Human Blood With Slosh Prevention
A NA study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03018548 is a NA study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 40 participants.
The verdict
NCT03018548, a NA study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
To monitor changes in indicators of red cell damage such as extracellular hemoglobin, potassium (K-ABL), and lactate dehydrogenase (LD) post blast exposure.
Interventions
- OTHER blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-01 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03018548
The ClinicalTrials.gov registry entry for NCT03018548 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which blood draw is the first listed.
NCT03018548 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03018548 about?
NCT03018548 is a clinical study titled "Improvised Explosive Device (IED) Level Blasting of Human Blood With Slosh Prevention". To monitor changes in indicators of red cell damage such as extracellular hemoglobin, potassium (K-ABL), and lactate dehydrogenase (LD) post blast exposure.
What is the current status of trial NCT03018548?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2016-01. Estimated completion is 2016-12.
What interventions are being tested in trial NCT03018548?
The interventions under investigation include: blood draw (OTHER).
Who is sponsoring clinical trial NCT03018548?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.